Conditions That Mimic Peritoneal Implants
Several benign and malignant conditions can closely mimic peritoneal implants on imaging, including peritoneal lymphomatosis, tuberculous peritonitis, splenosis, granulomatous peritonitis from ruptured teratoma, and various systemic inflammatory processes.
Key Mimics by Category
Malignant Mimics
Peritoneal lymphomatosis: Non-Hodgkin lymphoma can present with ascites, omental infiltration, and peritoneal implants that are indistinguishable from carcinomatosis on CT 1. This is particularly important in AIDS patients, where bulky adenopathy may be absent. Paracentesis often fails to diagnose lymphoma, requiring surgical biopsy or laparoscopy for definitive diagnosis 1.
Peritoneal sarcomatosis: Primary or metastatic sarcomas can produce peritoneal-based soft tissue masses similar to carcinomatosis 2, 3.
Infectious Mimics
- Tuberculous peritonitis: This atypical infection creates peritoneal thickening, nodules, and ascites that closely resemble malignant implants 2, 3. Look for associated findings like mesenteric lymphadenopathy with central necrosis and systemic TB risk factors.
Benign Tumor-Related Mimics
Granulomatous peritonitis from ruptured teratoma: Mature ovarian teratomas can rupture, causing peritoneal and omental implants that mimic carcinomatosis 4. This occurs despite the tumor being benign. Histologic diagnosis is essential before proceeding with full oncologic resection when peritoneal implants are unexpectedly found with an ovarian mass 4.
Splenosis: Autotransplantation of splenic tissue following traumatic splenic rupture creates peritoneal implants that can mimic endometriosis or metastatic disease 5. These implants should not be removed as they may compensate for the asplenic state 5.
Systemic and Inflammatory Mimics
The broad categories include 2:
- Tumor-like conditions (desmoid fibromatosis, inflammatory pseudotumor)
- Systemic processes (amyloidosis, extramedullary hematopoiesis)
- Fat-based conditions (sclerosing mesenteritis, omental infarction)
Imaging Limitations
CT has significant limitations in distinguishing benign from malignant peritoneal disease, particularly for lesions <5mm 6. The addition of oral and rectal contrast can help differentiate peritoneal implants from adjacent bowel 6.
FDG-PET/CT may provide additional specificity but shares similar limitations for subcentimeter lesions and can show false positives from inflammation or post-surgical changes 6.
Critical Clinical Pitfalls
Do not assume all peritoneal implants are malignant: Patient history (trauma for splenosis, TB exposure, AIDS risk) and clinical context are essential 2, 1, 5.
Obtain tissue diagnosis when findings are atypical: Paracentesis may be inadequate; surgical biopsy, laparoscopy, or image-guided biopsy may be necessary 1, 4.
Expert pathology review is mandatory: The distinction between invasive and non-invasive implants (as in serous borderline tumors) requires specialized expertise and significantly impacts management 7.
Consider lymphoma in AIDS patients: Even without bulky adenopathy, peritoneal lymphomatosis should be in the differential for AIDS patients with peritoneal disease 1.